Log In
Print this Print this

Stanate, stannsoporfin

  Manage Alerts
Collapse Summary General Information
Company InfaCare Pharmaceutical Corp.
DescriptionInhibitor of bilirubin formation
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationLiver disease
Indication DetailsTreat hyperbilirubinemia in infants
Regulatory Designation
PartnerRecordati S.p.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today